In an attempt to clarify the consequences of these mutations, Xu et al. introduced a p53-null mutation into the BRCA1 conditional-mutant mice, demonstrating that when both genes were mutated, mammary tumor formation was dramatically accelerated [59]. The gene discussed is TP53; the disease is breast cancer.